Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» dementia-related psychosis
dementia-related psychosis
FDA rejects Acadia’s bid for Nuplazid approval in dementia-related psychosis
MedCity News
Mon, 04/5/21 - 02:37 pm
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
FDA
Acadia Looks to Expand Drug Beyond Parkinson’s Disease Psychosis
Xconomy
Fri, 12/6/19 - 09:28 pm
Acadia Pharmaceuticals
cilnical trials
Parkinson's Disease Psychosis
dementia-related psychosis
Acadia calls early halt to Nuplazid psychosis trial after promising interim results
Fierce Pharma
Tue, 09/10/19 - 11:41 pm
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
Trial win could drive Acadia's Nuplazid to new use
Biopharma Dive
Mon, 09/9/19 - 08:00 pm
Acadia Pharmaceuticals
Nuplazid
dementia-related psychosis
clinical trials
FDA
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
CP Wire
Mon, 09/10/18 - 11:43 am
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
Parkinson's Disease Psychosis
Under Fire for Risk/Efficacy Profile – Nuplazid Shows Potential for Treating Dementia-Related Psychosis
Mon, 09/10/18 - 09:53 am
Acadia
Nuplazid
pimavanserin
dementia-related psychosis
